CRISIL Ltd. is an Indian analytical company engaged in providing ratings, data, research, and risk and policy advisory services. It is the subsidiary of S&P Global, an American company. Founded in 1987, the company has its headquarters in Mumbai. For the quarter that ended in June 2022, the company reported a total income of Rs 703.84 crore, up 14.44% from the previous quarter that ended in March 2022. On 17 October 2022, the company’s market capitalisation stood at Rs 22,464 crore.
CRISIL Ltd. is listed on the Bombay Stock Exchange with the code 500092, and on the National Stock Exchange with the code CRISIL.
The company delivers independent opinions, actionable insights, and efficient solutions to more than 100,000 customers. Its businesses operate from the United States, the United Kingdom, China, Poland, Argentina, Singapore, Hong Kong, the United Arab Emirates, and India. The client portfolio includes micro, small and medium companies, investors, large corporates, and global financial institutions.
The company’s shareholding pattern on 30 June 2022 represented a promoter stake of 66.74%, an FII stake of 6.58%, a DII stake of 7.51%, and a public stake of 19.19%. S&P India LLC is the leading promoter with a 42.74% share, followed by S&P Global Asian Holdings Pte. Ltd. with a 15.78% share. The promoters decreased holdings from 66.79% to 66.74%, mutual funds increased holdings from 3.22% to 3.79%, and FIIs decreased holdings from 6.65% to 6.58% during the June 2022 quarter.
CRISIL Ltd.’s board of directors includes Mr John L Berisford, Mr Girish Paranjpe, Mr Ewout Steenbergen, Mr Amar Raj Bindra, Mr Yann Le Pallec, Mr Amish Mehta, Mrs Shyamala Gopinath, and Ms Vinita Bali. Walker Chandiok & Co. LLP are the company’s auditors. As of 30 June 2022, the company had a total of 7.30 crore shares outstanding.
On 17 October 2022, the company share’s closing price was Rs 3,078.20 on BSE. On NSE, its closing price was Rs 3075.50. The 52-week high for CRISIL Ltd.’s share price was Rs 3,863.55, while the 52-week low share price was Rs 2,540. By investing in the company’s shares, investors earned a six-month return of -8.47% and a one-year return of 3.36%.
The company’s peers include ICRA Ltd and CARE Ratings Ltd.
Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose